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Abstract 
In differentiated cells, aging is associated with hypermethylation of DNA regions 
enriched in repressive histone posttranslational modifications. However, the chromatin 
marks associated with changes in DNA methylation in adult stem cells during lifetime 
are still largely unknown. Here, DNA methylation profiling of mesenchymal stem cells 
obtained from individuals aged 2 to 92 identified 18735 hypermethylated and 45407 
hypomethylated CpG sites associated with aging. As in differentiated cells, 
hypermethylated sequences were enriched in chromatin repressive marks. Most 
importantly, hypomethylated CpG sites were strongly enriched in the active chromatin 
mark H3K4me1 in stem and differentiated cells, suggesting this is a cell type-
independent chromatin signature of DNA hypomethylation during aging. Analysis of 
scedasticity showed that interindividual variability of DNA methylation increased 
during aging in MSCs and differentiated cells, providing a new avenue for the 
identification of DNA methylation changes over time. DNA methylation profiling of 
genetically identical individuals showed that both the tendency of DNA methylation 
changes and scedasticity depended on non-genetic as well as genetic factors. Our results 
indicate that the dynamics of DNA methylation during aging depend on a complex 
mixture of factors that include the DNA sequence, cell type and chromatin context 
involved, and that, depending on the locus, the changes can be modulated by genetic 
and/or external factors. 
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Introduction 
Genomic DNA methylation is known to change during lifetime and aging (Jaenisch and 
Bird 2003). Some changes play important roles in development but others occur 
stochastically without any apparent biological purpose (Fraga 2009; Feil and Fraga 
2012). These molecular alterations, which are known as the epigenetic drift, are 
currently being investigated as they have been proposed to account for many age-related 
diseases (Bjornsson et al. 2004; Heyn et al. 2013; Timp and Feinberg 2013). Various 
recent studies using 1.5K and 27K Illumina methylation arrays have identified a group 
of gene promoters in blood that become hypermethylated during aging (Christensen et 
al. 2009; Rakyan et al. 2010; Teschendorff et al. 2010; Bell et al. 2012; Fernandez et al. 
2012). Interestingly, some of these studies have also shown that these DNA sequences 
are enriched in bivalent chromatin domains in embryonic stem cells (Rakyan et al. 
2010; Fernandez et al. 2012; Heyn et al. 2012) and repressive histone marks such as 
H3K9me3 and H3K27me3 in differentiated cells (Rakyan et al. 2010), and that many of 
them are also frequently hypermethylated in cancer. However, drawing conclusions 
from some of these studies is limited by their low genome coverage (less than 0.1%) 
and the location of the sequences analyzed (mainly at gene promoters). Further studies 
using HumanMethylation450 BeadChip and larger cohorts (Heyn et al. 2012; Hannum 
et al. 2013; Johansson et al. 2013) have, though, corroborated most of the previous 
observations with the 27K methylation arrays and have, in addition, identified new sets 
of genes that become hypermethylated and hypomethylated during aging in humans. 
Finally, a recent study that analyzed the genome wide DNA methylation status of 
newborns, middle-aged individuals and centenarians confirmed the results obtained 
with the methylation arrays and showed that aging is associated with overall 
hypomethylation, which primarily occurs at repetitive DNA sequences (Heyn et al. 
2012). Most of the above studies were conducted with whole blood and, consequently, 
changes in cell heterogeneity during aging could have affected the results (Calvanese et 
al. 2012; Houseman et al. 2012). However, some genes presented consistent changes in 
different tissues which indicates that, in some cases, the changes truly are associated 
with aging (Rakyan et al. 2010; Horvath et al. 2012). Interestingly, Houseman and 
colleagues (Houseman et al. 2012) have recently reported an algorithm that, using the 
DNA methylation values of certain genes, estimates the relative proportion of the 
different blood cell types in a specific sample. This algorithm was successfully used by 
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Liu and colleagues in a study to identify DNA methylation alterations associated with 
rheumatoid arthritis (Liu et al. 2013). 
In addition to the studies using blood, other works have identified specific DNA 
methylation signatures of aging in differentiated cell types including brain (Hernandez 
et al. 2011; Numata et al. 2012; Guintivano et al. 2013; Lister et al. 2013), muscle 
(Zykovich et al. 2014) and saliva (Bocklandt et al. 2011). Two studies have analyzed 
DNA methylation during aging in human adult stem cells: Bork and colleagues (Bork et 
al. 2010) used 27k methylation arrays to analyze the DNA methylation status of 
mesenchymal stem cells (MSCs) obtained from young (21–50 years) and old donors 
(53–85 years) and found similar DNA methylation changes over time during prolonged 
in vitro culture and in vivo aging. Using the same methylation arrays, Bocker and 
colleagues (Bocker et al. 2011) observed a bimodal pattern of methylation changes in 
older hematopoietic progenitor cells, with hypomethylation of differentiation-associated 
genes, as well as de novo methylation events resembling epigenetic mutations. Recent 
studies in mice have revealed a number of genome-wide alterations in DNA methylation 
(Taiwo et al. 2013) which might play an important role in the functional decline of 
hematopoietic stem cells during aging (Beerman et al. 2013). To study the role of DNA 
methylation in adult stem cell aging further, the present study used 
HumanMethylation450 BeadChips to characterize the genome wide DNA methylation 
status of bone marrow MSCs obtained from individuals aged between 2 and 92. We 
then systematically compared our results with previously published data to identify the 
chromatin signatures associated with DNA methylation changes in adult stem cells and 
to determine whether these changes were also present in other tissues. Finally, we 
analyzed monozygotic twins of different ages to determine the effect of genetic factors 
on the DNA methylation changes during aging identified in our study. 
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Results 
Global DNA methylation profiling in adult MSCs 
To identify DNA methylation changes during MSC aging we compared the DNA 
methylation status of 429789 CpG sites in 34 independently isolated primary MSC, 
obtained from individuals from 2 to 92-years old, using the HumanMethylation450 
BeadChip (Illumina®) (Supplemental Fig. S1 and Supplemental Table 1). 
Using an empirical Bayes moderated t-test (see Materials and Methods) we first 
identified 64142 autosomal CpG sites which were differentially methylated (dmCpGs) 
(FDR<0.05) between MSCs obtained from young (ages ranging from 2 to 22) and 
elderly (aged between 61 and 91) individuals. Hierarchical clustering of all samples 
using the dmCpGs alone enabled each sample to be correctly allocated to its 
corresponding age group (Figure 1A). Of the dmCpG sites, 18735 (29.20%) had 
become hypermethylated and 45407 (70.80%) hypomethylated with aging (Figure 1B 
and Supplemental Tables 2, 3). 
To study, from a functional genomics point of view, the characteristics of these dmCpG 
sites we first determined their distribution within the different regions of the CpG 
islands (Wu et al. 2010). Interestingly, both hyper- and hypomethylated CpG sites were 
enriched in non CpG islands (CGI) (chi-square test; p<0.001, OR=2.58 and p<0.001, 
OR=1.76 respectively) (Figure 1C) and in intragenic DNA regions (chi-square test; 
p<0.001, OR=1.23 and p<0.001, OR=1.34 respectively) (Figure 1D). 
To validate the results obtained with the methylation arrays, we randomly selected 5 of 
the sequences previously identified and analyzed their methylation status by bisulfite 
pyrosequencing in an independent cohort of 46 MSCs obtained from individuals from 7 
months to 80-years old (Supplemental Table 1). In total, in the validation phase we 
obtained information on the DNA methylation status of 950 CpGs. The sequences 
selected corresponded to the genes HAND2 and SIX2, which become hypermethylated 
with aging, and to the genes TBX15, PITX2 and HOXA11, which become 
hypomethylated. Bisulfite pyrosequencing results showed that all the sequences selected 
for validation displayed the same DNA methylation dynamics during aging as in the 
study samples (Figure 1 E). 
 
Tissue-specific DNA methylation changes during aging 
 Cold Spring Harbor Laboratory Press on October 15, 2014 - Published by genome.cshlp.orgDownloaded from 
6 
 
Global DNA methylation patterns are tissue/cell type-specific (Calvanese et al. 2012). 
To determine whether the CpG sites displaying DNA methylation changes during aging 
in adult stem cells are also affected in differentiated tissues, we used the same workflow 
described in the previous section to analyze the data obtained in previous aging studies 
which used the same methylation arrays with samples from blood (human whole blood 
from a mixed population of 426 Caucasian and 230 Hispanic individuals, with ages 
ranging from 19 to 101) and brain (neuronal and glial cells, from post mortem frontal 
cortex of 29 healthy individuals (14 male, 15 female, aged 32.6 ± 16.1) (Guintivano et 
al. 2013; Hannum et al. 2013) (Supplemental Fig. S1). To reduce confounding factors 
in the blood dataset, we first corrected for cellular heterogeneity with respect to the 
major cell subtypes (Houseman et al. 2012) to filter out only those associations which 
were the consequence of aging. Using this approach we identified 63512 
hypermethylated and 60155 hypomethylated sequences in blood (FDR<0.05), 11603 
hypermethylated and 14143 hypomethylated sequences in glial cells (FDR<0.05) and 
5171 hypermethylated and 2380 hypomethylated sequences in neural cells (FDR<0.05) 
(Supplemental Fig. S2 and Supplemental Tables 4, 5). As in MSCs, hypomethylated 
cytosines in the differentiated cells preferentially occurred at both non-CGI regions 
(chi-square test; blood, p<0.001, OR=2.35; neural, p<0.001, OR=1.74; glial, p<0.001, 
OR=3.03) and at intragenic regions (chi-square test; blood, p<0.001, OR=1.11; neural, 
p<0.001, OR=2; glial, p<0.001, OR=1.89) (Supplemental Fig. S2). However, in brain 
samples (neuronal and glial cells), hypermethylated cytosines occurred preferentially at 
both non-CGI regions (chi-square test; neural, p<0.001, OR=1.43; glial, p<0.001, 
OR=1.43) and at intragenic regions (chi-square test; neural, p<0.001, OR=1.1; glial, 
p<0.001, OR=1.1), while they occurred preferentially in both CGIs (chi-square test; 
p<0.001, OR=3.5) and at promoter regions (chi-square test; p<0.001, OR=1.49) in 
blood samples (Supplemental Fig. S2). 
To identify possible cell type-independent DNA methylation signatures of aging, we 
created two additional datasets containing the hyper- and hypomethylated probes from 
selected subsets of the different tissues analyzed (Figure 1F). This approach showed 
only a small overlap between MSC and differentiated cells (42 hypomethylated and 38 
hypermethylated), suggesting that systemic DNA methylation changes during aging are 
restricted to specific regions of the genome (Figure 1F and Supplemental Tables 6, 
7). 
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Hypermethylated CpG sites during aging are associated with repressive chromatin 
marks 
In blood, DNA hypermethylation during aging has been shown to occur at gene 
promoters enriched in repressive histone marks such as H3K9me3 and H3K27me3 
(Rakyan et al. 2010). To identify possible chromatin signatures associated with DNA 
hypermethylation during aging in adult MSCs, we compared our methylation data with 
previously published data on a range of histone modifications and chromatin modifiers 
in 10 different cell types obtained from healthy individuals (see Materials and 
Methods). In the present study we found statistically significant associations with the 
repressive histone marks H3K9me3, H3K27me3 and EZH2 in most differentiated 
ENCODE cell lines (Fisher´s exact test; p<0.001) (Figure 2), which is in line with 
previously published data (Rakyan et al. 2010). To determine whether these 
observations can be extrapolated to other cell types, we used the same approach to 
analyze the CpG sites which are hypermethylated during aging in blood, neural and 
glial cells (Guintivano et al. 2013; Hannum et al. 2013) (Supplemental Table 4). The 
results showed that hypermethylated CpG sites in blood and brain were enriched in the 
same chromatin marks identified in the adult MSCs (Figure 2), suggesting that 
chromatin context is an important cell type-independent mark of DNA 
hypermethylation during aging. Analysis of the 38 commonly hypermethylated CpG 
sites in blood, MSCs and neural and glial cells also showed statistically significant 
associations (FDR<0.05) with the repressive histone marks H3K9me3, H3K27me3 and 
EZH2 found in some types of differentiated cells (Figure 2). 
 
DNA hypomethylation during aging preferentially occurs at H3K4me1 rich sites 
To identify chromatin marks associated with CpG sites hypomethylated in aged MSCs, 
we aligned the DNA sequences identified in our study with the same database of histone 
modifications and chromatin modifiers described in the previous section. Of note is the 
fact that hypomethylation largely occurred at regions occupied by the active histone 
mark H3K4me1 in most of the ENCODE cell lines (FDR<0.05) (Figure 2).  
To determine whether these associations occurred in differentiated cells, we used the 
same approach to analyze CpG hypomethylation during aging in blood, neural and glial 
cells (Guintivano et al. 2013; Hannum et al. 2013) (Supplemental Table 5). Blood and 
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brain samples showed similar enrichment patterns to those of the MSCs in that 
hypomethylated CpG sites were preferentially located at regions enriched in H3K4me1 
(Figure 2). Interestingly, the analysis of the 42 commonly hypomethylated CpG sites in 
blood, MSCs and neural and glial cells only showed statistically significant associations 
with H3K4me1 (FDR<0.05) (Figure 2A). 
 
Dynamics of interindividual DNA methylation variability during aging 
As in most previous studies on DNA methylation and aging, our analytical design 
allowed the identification of DNA sequences showing a specific tendency to change 
(hyper- or hypomethylation) during aging, but not other putative DNA regions 
exhibiting no change tendency (i.e., sequences that do not become hyper- or 
hypomethylated with aging but rather show an increase or a decrease in interindividual 
variability). To address this issue, we carried out an alternative data analysis on our 
MSCs based on the aging-dependent behavior of interindividual variability (i.e. DNA 
methylation scedasticity). Interindividual variability was higher in MSCs obtained from 
older individuals than in those obtained from younger individuals (Figure 3A). Analysis 
of the scedasticity identified 16243 heteroscedastic CpG sites, of which 2437 were 
convergent and 13806 divergent. We also identified 124611 homoscedastic CpG sites, 
68927 showing low interindividual variability in both young and old individuals (LV) 
and 55684 showing high interindividual variation in both populations (HV) (see 
Materials and Methods) (Figure 3B, C and Supplemental Tables 8-11).  
We studied these sequences from a functional genomics standpoint to identify factors 
associated with the behavior of DNA methylation changes during aging. We observed 
that divergent and HV CpG sites were preferentially enriched in non-CGIs (chi-square 
test; p<0.001, OR=1.59 and p<0.001, OR=1.58 respectively), and convergent and LV 
CpG sites in CGIs (chi-square test; p<0.001, OR=1.11 and p<0.001, OR=5.00 
respectively) (Figure 3D). Both divergent and convergent sequences were more 
abundant in intragenic regions (chi-square test; p<0.001, OR=1.38 and p<0.001, 
OR=1.16 respectively), with HV being more frequently found in intergenic regions (chi-
square test; p<0.001, OR=1.50), and LV in promoter regions (chi-square test; p<0.001, 
OR=3.62) (Figure 3D). 
To determine whether scedasticity behavior can also identify DNA methylation changes 
during aging in differentiated cells we repeated these same analyses on previously 
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published blood DNA methylation data (Hannum et al. 2013). As Hannum et al.’s 
cohort contains DNA methylation data on more than 600 individuals, statistical analyses 
were carried out using a Brown-Forsythe test (see Materials and Methods). To discount 
a possible confounding effect of cell heterogeneity in the analysis of the scedasticity in 
blood, in addition to applying the algorithm described by Houseman et al. (Houseman et 
al. 2012), we carried out in silico functional analysis of the groups of genes established 
according to the behavior of the variance (see Materials and Methods). These analyses 
showed no significant associations between these groups of genes and any of the blood 
cell lineages examined (Supplemental Tables 12 and 13). As in MSCs, interindividual 
variability was higher in blood obtained from older individuals than in blood obtained 
from younger individuals (Figure 4A). Furthermore, in line with the findings for adult 
MSCs, in differentiated cells, the analyses identified 19454 heteroscedastic CpG sites, 
of which 4037 were convergent and 15417 divergent. Of the homoscedastic CpG sites, 
92074 showed LV in both young and old individuals and 92753 showed HV in both 
populations (Figure 4B, C).  
 
The role of genetic factors on DNA methylation changes during aging 
To study the role of genetic factors on DNA methylation changes during aging we used 
HumanMethylation450 BeadChips to analyze the DNA methylation status of 24 
monozygotic twins from two age groups (young, 21-22-yo and old, 58-66-yo). The 
effect of genotype was assessed comparing the Euclidean distance (ED) and the 
interindividual variability in methylation values between old and young monozygotic 
(MZ) pairs. To reduce possible bias due to cell heterogeneity, DNA methylation data 
was corrected with the algorithm described by Houseman (Houseman et al. 2012). As in 
the larger cohort previously analyzed (Figure 4), interindividual DNA methylation 
variability substantially increased during aging in the MZ twins (Figure 5A). 
Interestingly, mean ED between MZ twins also increased (> 2-fold) with age in 46763 
CpG sites (Figure 5B and Supplemental Table 14), which indicates that, at these CpG 
sites, the increase in interindividual methylation variability depends, at least in part, on 
non-genetic factors. In 24782 of these sequences (Figure 5B and Supplemental Table 
15) the increase in ED (> 2-fold) was higher than could be accounted for solely by 
interindividual variability, suggesting that, in these CpG sites, genetic factors play a less 
important role in the regulation of DNA methylation changes during aging. However, in 
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21908 of these sequences (Figure 5B and Supplemental Table 16), the increase in ED 
(> 2-fold) was less than could be accounted for solely by interindividual variability, 
which suggests that, in contrast, at these CpG sites, genetic factors are more relevant for 
the regulation of DNA methylation during aging. 
Although the general trend was an increase in ED with age, for 22542 CpG sites ED 
between older MZ pairs decreased (> 2-fold) (Figure 5B and Supplemental Table 17). 
As the EDs between older MZ individuals are greater than those between younger MZs 
in more than half the sequences identified, our results support the notion that, in general, 
DNA methylation patterns diverge with age, even in genetically identical individuals. In 
11624 sequences (Figure 5B and Supplemental Table 18) the decrease in ED (> 2-
fold) was lower than could be accounted for solely by interindividual variability, which 
suggests that, in these CpG sites, genetic factors play a more important role in the 
regulation of DNA methylation changes during aging. In 10883 sequences (Figure 5B 
and Supplemental Table 19), the decrease in ED was higher than could be accounted 
for solely by interindividual variability, indicating that in these CpG sites, genetic 
factors play a less important role in the regulation of DNA methylation during aging. As 
in the analysis of the previously published blood DNA methylation data, in silico 
functional analysis of the groups of genes identified in the monozygotic twins 
(Supplemental Tables 20,21), suggested that, after correcting with the Houseman 
algorithm, cell heterogeneity had little impact on the Euclidean distances for changes in 
DNA methylation with age.  
Comparative analysis of the interindividual variation and the EDs suggests that the 
effect of genotype on the regulation of DNA methylation changes during aging was 
locus-specific. Thus, to identify those DNA regions differentially affected by the 
genotype, we used Circos representations to study the genomic distribution of CpG sites 
which showed changes in ED with age (Figure 5C). The results demonstrated that 
whilst CpG sites showing a decrease, or no difference, in ED between young and old 
MZs presented a random distribution, those showing an age-dependent increase in ED 
were strongly enriched in subtelomeric DNA regions. The greatest changes occurred at 
chromosomes 11 and 19 and, in general, clustering occurred at the same genomic 
regions in both young and old twins.  
To study the effect of the genotype on DNA methylation and its interindividual 
variability during aging we analyzed the Twins data using similar strategies to those 
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described in previous sections, identifying 41987 hypermethylated, 56923 
hypomethylated, 1018 convergent, 1635 divergent, 58680 HV and 59795 LV CpG sites 
(data not shown). The comparison of EDs between young and old MZ pairs for these 
groups of genes showed that the effect of genotype depended on the tendency and the 
scedasticity of the change (Figure 5D).  
ED increased (>2-fold) with age in 9.5% of the hypomethylated and in 14% of the 
hypermethylated CpGs, suggesting that genetic factors have a greater effect on the 
former during aging (Figure 5D and Supplemental Tables 22, 23). ED increased (>2-
fold) in most (83.73%) of the divergent CpG sites and decreased (>2-fold) in most 
(66.7%) of the convergent CpG sites (Figure 5D and Supplemental Tables 24, 25). 
However, changes in interindividual variability were higher than the increase or 
decrease in ED (Figure 5D), which indicates that genetic factors play a role in the 
regulation of DNA methylation of these DNA regions during aging. Interestingly, ED 
also increased in most of the HV and LV sequences (>2-fold) during aging (Figure 5D). 
Furthermore, in most CpG sites, the increase in ED between the MZ twins was higher 
than the interindividual variability changes during aging (Figure 5D), suggesting that 
genotype has little effect on epigenetic drift in homoscedastic DNA regions. 
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Discussion 
Recent studies have shown that DNA methylation is altered during aging in a number of 
differentiated cell types (Rakyan et al. 2010; Teschendorff et al. 2010; Bell et al. 2012; 
Fernandez et al. 2012; Heyn et al. 2012; Numata et al. 2012; Guintivano et al. 2013; 
Hannum et al. 2013; Johansson et al. 2013). Here, we studied the dynamics and the 
context of DNA methylation changes during aging in human adult stem cells as they 
have been proposed to play an important role in aging (Sharpless and DePinho 2004). 
Indeed, a recent study in mice showed that epigenomic alterations of the DNA 
methylation landscape contribute to the functional decline of hematopoietic stem cells 
(HSCs) during aging (Beerman et al. 2013). To analyze our DNA methylation data, we 
first used an analytical strategy similar to that used in most of the previous studies on 
DNA methylation and aging (i.e. linear models). Using this approach, we identified 
18735 CpG sites which were hypermethyated and 45407 which were hypomethylated 
during aging in MSCs, which provides support for the idea that, as in blood (Heyn et al. 
2012), aging is associated with global DNA hypomethylation in MSCs. In addition, we 
validated 5 of the genes identified through the methylation arrays (HAND2, SIX2, 
TBX15, PITX2, and HOXA11) by bisulfite pyrosequencing, using an independent 
sample set of 46 MSCs obtained from individuals from 7 months to 80-years old. The 
results corroborated the data obtained from the methylation arrays and suggest that our 
genome-wide data can be extrapolated to independent sample sets of MSCs. HAND2 
and SIX2 genes code for transcription factors and have been also found hypermethylated 
in several cancer types (Rauch et al. 2006; Tong et al. 2010; Jones et al. 2013). In 
contrast, the genes which are hypomethylated during MSC aging, TBX15, PITX2, and 
HOXA11, code for transcription factors involved in several differentiation and 
developmental processes (Singh et al. 2005; Gross et al. 2012; Gage et al. 2014). 
Interestingly, 80 of the differentially methylated sequences identified in the MSCs were 
present in both blood and brain, which is in line with previous observations that suggest 
the existence of systemic DNA methylation changes during aging (Rakyan et al. 2010; 
Heyn et al. 2012). However, as many of the sequences were not common to different 
tissues, our data indicate that, as has recently been proposed (Christensen et al. 2009; 
Day et al. 2013) systemic changes are restricted to specific loci, and cell type plays an 
important role in the regulation of DNA methylation changes over time.  
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The factors determining the behavior of DNA methylation during aging have received 
much attention during the last few years. Recent works have shown that genes which 
are hypermethylated in blood during aging are associated with the presence of bivalent 
chromatin domains in embryonic stem cells (Rakyan et al. 2010; Teschendorff et al. 
2010; Fernandez et al. 2012; Heyn et al. 2012) and with repressive histone marks 
(H3K27me3/H3K9me3) in differentiated cells (Rakyan et al. 2010). Our data indicate 
that the same repressive histone marks in differentiated cells are also present in 
sequences in those MSCs which are hypermethylated during aging, implying that, 
independent of morphogenic potential and/or cell type, these repressive histone marks 
are associated with DNA methylation gain during aging. Of note, our data provide new 
evidence that sequences which are hypomethylated in MSCs and differentiated cells 
during aging are strongly enriched in the active chromatin mark H3K4me1, which 
suggests that this histone modification is a cell type-independent chromatin signature of 
DNA hypomethylation during aging. Interestingly, H3K4me1 has recently been 
associated with enhancers (Rada-Iglesias et al. 2010), genomic regions that play a 
fundamental role in cis-regulation of gene function. In addition, a recent study has 
shown that DNA hypomethylation within specific transposable elements is associated 
with tissue-specific enhancer marks, including H3K4me1, suggesting that these 
sequences might play an important role in tissue-specific epigenetic gene regulation 
(Xie et al. 2013), which implies that H3K4me1-associated DNA hypomethylation could 
play a role in the deregulation of gene expression during aging (Bahar et al. 2006). 
Further parallel studies analysing DNA hypomethylation in enhancers and gene 
expression during aging should shed light on this matter. Collectively, our data indicate 
that, although there are few altered DNA sequences which are common to different cell 
types, the chromatin signatures associated with DNA hyper- and hypomethylation 
during aging were similar for different tissues, supporting the notion that chromatin 
context is associated with the dynamics of systemic DNA methylation changes during 
aging. The reasons why the repressive histone marks H3K27me3/H3K9me3 favor 
hypermethylation and the active histone mark H3K4me1 promotes hypomethylation 
during aging are not known. A simple explanation could be the preferential location of 
DNA methyltransferases (DNMTs) at repressive chromatin regions (Jeong et al. 2009). 
Repressive chromatin regions could be predisposed to becoming hypermethylated due 
to the abundance of DNMTs. In contrast, active chromatin regions would be more 
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susceptible to losing methylation because the low levels of DNMTs at these regions 
make it more difficult to maintain DNA methylation patterns after mitosis. This 
possibility is supported by the fact that postmitotic tissues such as brain (Numata et al. 
2012; Guintivano et al. 2013) and muscle (Zykovich et al. 2014) present far fewer 
hypomethylated sequences during aging than highly mitotic cells such as blood and 
MSCs. Further studies analyzing the genome wide distribution of DNMTs during aging 
are needed to support this possibility.  
One possible limitation of our study is the purification and the in vitro culture of MSCs 
(Calvanese et al. 2008; Choi et al. 2012), although this should have no great impact 
when comparing young and old MSCs as both sets of samples were cultured under 
exactly the same conditions. Moreover, cell heterogeneity, which is a major issue in 
DNA methylation studies (Houseman et al. 2012; Guintivano et al. 2013), has less 
impact in relation to MSCs as they are more homogeneous than blood cell populations. 
However, to minimise the impact of cell heterogeneity in our analysis of blood we 
corrected DNA methylation data with a recently published algorithm (Houseman et al. 
2012), which yielded slightly different sequences to those previously proposed, 
suggesting that some of the DNA changes previously identified might be cell-type 
dependent. However, as this algorithm considers only the major cell subtypes, possible 
variations driven by minor subtypes would not be detected. Another limitation of our 
study is that the differences in the number of individuals analyzed and different data 
analyses undertaken make difficult the interpretation of the comparison of age-
dependent DNA methylation changes in different cell types. However, the conserved 
pattern of chromatin signatures in stem and differentiated cells suggests that 
H3K9me3/H3K27me3 and H3K4me1 are truly tissue-independent histone marks of 
DNA hyper- and hypomethylation respectively during aging. 
As in most previous studies on DNA methylation and aging, CpG sites showing DNA 
methylation changes during lifetime associated with a specific tendency (i.e. hyper- or 
hypomethylation) were identified. However, using this analytical approach means that 
other possible changes occurring at CpG sites displaying high interindividual variability 
in both young and old individuals and/or age-dependent interindividual variability are 
overlooked. To address this issue, we re-analyzed the DNA methylation data to 
characterize the age-dependent interindividual variability (i.e. scedasticity).  
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Using this approach we identified 16243 heteroscedastic (2437 convergent and 13806 
divergent), and 55684 homoscedastic CpG sites with high (HV) and 68927 with low 
(LV) interindividual variability. Most of these CpG sites were not identified through 
linear model analysis, leading us to suggest that DNA methylation changes during aging 
might be more frequent than has previously been thought. Interestingly, although there 
were some CpG sites that converged during aging, most of the heteroscedastic changes 
were divergent, providing support for the notion that interindividual DNA methylation 
variability increases during lifetime (Gemma et al. 2013; Ong and Holbrook 2013). 
Although the behavior adults stem cell populations during aging is still poorly 
understood (Pollina and Brunet 2011), the clonal expansion or decline of specific cell 
populations could affect the interpretation of changes of interindividual DNA 
methylation variability with aging. As it has been proposed that the number of MSCs 
declines with age (Stolzing et al. 2008), it is possible that the increase in interindividual 
variability might in fact be even larger than was observed in our study.  
Functional genomics analyses of the groups of CpG sites established according to the 
behavior of the variance revealed that low variable CpG sites were enriched in CpG 
islands and gene promoters. As DNA methylation occurring at CpG island promoters 
has been proposed to play an important role in gene regulation (Bird 1986; Bird and 
Wolffe 1999; Calvanese et al. 2012), our results could indicate that the DNA 
methylation involved in gene regulation is protected against the stochastic epigenetic 
changes that occur during lifetime (Feil and Fraga 2012). Interestingly, analysis of the 
interindividual variability of DNA methylation during aging in blood, showed that, as in 
adult stem cells, the DNA methylation patterns of differentiated cells also diverge with 
age, thereby supporting the notion that a systemic epigenetic drift occurs during the 
lifetime of higher organisms (Feil and Fraga 2012; Issa 2014). To confirm that the 
sequences identified in blood after correcting with the Houseman algorithm were not 
affected by cell heterogeneity, we carried out in silico functional analysis to discard a 
possible blood cell lineage-dependent regulation. The analyses showed no meaningful 
associations, which further supports our contention that, after correcting with the 
Houseman algorithm, cell heterogeneity had a minor impact on our blood DNA 
methylation data. 
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Previous reports have demonstrated that genetic factors play an important role in the 
regulation of DNA methylation during aging (Heijmans et al. 2007; Coolen et al. 2011; 
Gertz et al. 2011; Bell et al. 2012). To determine whether the effect of genotype is 
different depending on the intrinsic behavior of the DNA changes during aging at each 
specific CpG site, we analyzed the DNA methylation status of monozygotic twins of 
different ages. The results showed that interindividual variability increased with aging, 
in agreement with the notion that epigenetic drift during lifetime occurs even in 
genetically identical individuals (Fraga et al. 2005; Wong et al. 2010; Pirazzini et al. 
2012; Talens et al. 2012; van Dongen et al. 2012). However, our results also showed 
that the DNA methylation status of some CpG sites may converge during lifetime. 
Specifically, the analysis of genetically identical individuals revealed that the effect of 
genotype depended on the intrinsic behavior of the DNA methylation changes during 
aging. For example, although the mechanisms underlying methylation convergence are 
still largely unknown, our MZ data indicate that genetic factors must be involved, at 
least in part, as the intrapair changes were similar to, or even less than, the 
interindividual variations. In addition, in contrast to the convergent and divergent CpG 
sites, genotype seems to play a less important role in whether the CpG sites display high 
or low interindividual variability, as evidenced by the fact that the increase in ED in the 
homoscedastic sequences for MZ twin pairs during aging was higher than the 
differences explained by interindividual variability. Of particular note is the finding that 
genotype had the lowest effect on the CpG sites, displaying high interindividual 
variability in young and old individuals, evidenced by the increase Euclidean distance in 
MZ twins during aging being similar to or even higher than the increase in 
interindividual variability. Our results indicate that these CpG sites, which have 
received little attention until now, might be important targets of environmental and/or 
stochastic epigenetic variation during development and aging. Although we have 
reduced the effect of cell heterogeneity and immune status over time (Allegretta et al. 
1990) using the Houseman algorithm (Houseman et al. 2012) and by performing several 
functional in silico analyses of the groups of the genes showing age-related changes in 
Euclidean distance, we cannot completely discount a partial effect of these in our 
results. 
Our data indicate that the differences in the effect of genotype on DNA changes during 
lifetime depend largely on the genomic region involved, which is in agreement with 
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previously published data (Wong et al. 2010). In line with this, the greatest DNA 
methylation changes for MZs were clustered at subtelomeric DNA regions, which 
suggests that the regulation of DNA methylation at these sequences is largely 
independent of genetic factors. Interestingly, subtelomeric DNA methylation has been 
shown to be affected by environmental factors (unpublished observations). It is worth 
noting that, although for most CpG sites the ED in young twins was lower than for older 
twins, they still clustered in the same subtelomeric regions, providing support for the 
previous proposal that epigenetic drift starts early in life (Martino et al.; Kaminsky et al. 
2009; Ollikainen et al. 2010; Wong et al. 2010) and accumulates during lifetime at 
particular CpG sites that, for still unknown reasons, evade the control of genetic factors 
(Fraga 2009). 
Collectively, our results indicate that the dynamics of DNA methylation during lifetime 
in humans is associated with a complex mixture of factors. These include the DNA 
sequence itself, tissue type and, in particular the chromatin context, where repressive 
histone modifications such us H3K9me3 and H3K27me3 are related to DNA 
hypermethylation and, most notably, the active histone mark H3K4me1 is related to 
DNA hypomethylation. Finally, depending on the locus, the changes appear to be 
modulated by genetic and/or external factors. 
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Materials and methods 
Isolation and culture of MSCs 
MSCs were purchased from Lonza (Verviers, Belgium), Millipore (Billerica, MA, 
USA), and Inbiobank. (San Sebastian, Spain) or directly obtained from young and 
elderly donors. After informed consent, bone marrow aspirates were obtained from one 
group of patients and, from a second group, bone scrapings were obtained following hip 
replacement surgery. Mononuclear cells were isolated by Ficoll density centrifugation 
(400 g, 25 min, 20C), washed twice by sedimentation with phosphate buffer (300 g, 5 
min) and the cells resuspended in MSC medium (DMEM plus 10% FBS) and seeded 
into culture flasks (Nunc, Roskilde, Denmark) at 1.5x10e5 cells/cm2 and allowed to 
adhere for 24 hours. MSCs were then cultured (37C, 5% CO2) in MSC medium. DNA 
methylation analyses were carried out at cell passages 4-6 (Supplemental Table 1). 
MZ twins samples 
Genomic DNA from 24 samples from the Italian Twin Registry, corresponding to 12 
pairs of MZ twins, were extracted from buffy coats following standard procedures. Two 
different age groups were included for array-based DNA methylation profiling; one 
included individuals between 21 and 22 years old (young MZ twins), and the other 
individuals between 58 and 66 (old MZ twins). The sample distribution by gender was 
the same in both groups. 
Genome-wide DNA methylation analysis with high-density arrays 
Microarray-based DNA methylation profiling was performed with the 
HumanMethylation450 BeadChip (Bibikova et al. 2011). Bisulfite conversion of DNA 
was performed using the EZ DNA Methylation Kit (Zymo Research, Orange, CA) 
following the manufacturer’s procedures, with the modifications described in the 
Infinium Assay Methylation Protocol Guide.  Processed DNA samples were then 
hybridized to the BeadChip (Illumina), following the Illumina Infinium HD Methylation 
Protocol. Genotyping services were provided by the Spanish "Centro Nacional de 
Genotipado” (CEGEN-ISCIII)" (www.cegen.org).  
Datasets of blood and brain samples 
DNA methylation data of blood (Hannum et al. 2013) and brain (neuron and glia) 
(Guintivano et al. 2013) samples produced with the HumanMethylation450 BeadChip 
were used to compare with the results obtained in MSCs. DNA methylation β value data 
was downloaded from GEO accession numbers GSE40279 and GSE41826. The data 
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analysis workflow is outlined in Supplemental Fig. S1. 
HumanMethylation450 BeadChip data preprocessing 
IDAT files from the HumanMethylation450 BeadChip were processed further using the 
R/Bioconductor package minfi (Hansen and Aryee). In order to adjust for the different 
probe design types present in the HumanMethylation450 BeadChip architecture, red and 
green signals from the IDAT files were corrected using the SWAN algorithm 
(Makismovic et al. 2012). No background correction or control probe normalization 
was applied. Probes where at least two samples had detection p-values over 0.01 were 
filtered out. In accordance with Du et al. (Du et al. 2010), both beta values and m-
values were computed and employed across the analysis pipeline. M-values were used 
for all the statistical analyses, assuming homoscedasticity (with the exception of the 
blood heterogeneity adjustment), while beta values were mostly used for the intuitive 
interpretation and visualization of results. 
Filtering confounding probes 
Probes located in the X/Y chromosomes were removed from the dataset when   
differential methylation profiles were analyzed. Probes that had been found to 
cohybridate with probes in the sex chromosomes (Lemire et al. 2013) were also 
removed. We used the information from the SNP137Common track from the UCSC 
Genome Browser (Sherry et al. 2001) in order to remove those probes with an SNP 
located inside their 2bp central region. 
Batch effect correction 
Multidimensional Scaling (MDS) was employed to detect whether there was any 
significant batch effect depending on the different HumanMethylation450 BeadChip 
plates which comprised the experiments. When there was, the ComBat method 
implemented in the R/Bioconductor package sva (Leek et al.) was used to adjust the 
datasets accordingly, employing the variable age as the outcome of interest and the 
sample plate as a batch covariate. 
White blood cell heterogeneity adjustment 
Methylation data for the Blood and Twins datasets was adjusted for blood cell 
heterogeneity, with respect to the major cell subtypes, using the method described in 
Houseman et. al. (Houseman et al. 2012). In order to feed this method, we used the 
original 27k database of purified white blood cell subtypes included in the original 
implementation of the algorithm. The correction was performed on the beta values due 
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to the fact that the 27k database was expressed using those units. M-values were 
obtained from the corrected beta values for subsequent downstream analyses. 
Detection of differentially methylated probes 
For the MSC dataset, the 34 samples were divided into two groups: young (ages ranging 
from 2 to 22) and old (ages between 61 and 92). Similarly, samples in the Twins dataset 
were divided into young (ages ranging from 21 to 22) and old (age between 58 and 66). 
For the neuron and glia datasets, the two groups were defined by taking those 
individuals whose age was below the 33rd percentile (young) and above the 66th 
percentile (old). Blood samples were not divided into groups, and the age predictor was 
used as a quantitative covariate. For the MSCs, Twins, neuron and glia datasets, 
significant methylation of a probe was determined by the moderated t-test implemented 
in the R/Bioconductor package limma (Smyth 2005). Probes in the blood dataset were 
tested with a linear regression. A linear model, with methylation level as response and 
age as the only predictor, was used on all the datasets. P-values were corrected for 
multiple testing using the Benjamini-Hochberg method for controlling the false 
discovery rate (FDR). A significance level of 0.05 was employed to determine 
differentially methylated probes. An additional threshold of effect size was applied, 
meaning that only those probes with the strongest differences between groups (the top 
70%) were selected.  The application of this threshold is essential to remove those 
differences prone to coming from technical artifacts, and consequently ensure a more 
biologically sound statistical data analysis (Pan et al. 2005). Our threshold was adjusted 
according to the differences in M-values between groups in the brain and MSC datasets 
and the slope coefficients extracted from the blood dataset linear regression model. 
Analysis of variability trends 
To analyze aging-dependent behavior of DNA interindividual variability (i.e. DNA 
methylation scedasticity), two groups, corresponding to young (samples where age was 
below the 33rd percentile) and old (those where age is above the 66th percentile) 
individuals, were selected for all the datasets. This separation allows the method to 
focus on the global tendency of the variability, and be less dependent on a fixed, 
underlying model. A Brown-Forsythe test for the equality of variances was used to 
determine which probes in the blood dataset had significantly different variability in 
methylation between the two groups. For the remaining datasets, and due to the small 
number of available samples and low statistical power for conducting a variance test, a 
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simple descriptive approach was used, labeling a probe as having a significant 
difference in methylation variability when the absolute value of the base-2 logarithm of 
the change of the variances for the two groups was greater than 3 fold. We did not apply 
any threshold of effect size for any of the datasets. For the blood dataset, p-values were 
corrected for multiple testing using FDR (Benjamini-Hochberg method) and a 
significance level of 0.05 used to determine which probes had a significant trend in 
variability. Two special subsets of probes with no significant trends in variability were 
generated: one, named HV (High Variance), for those probes with variance values 
above the 75th percentile of the whole set of variances for both the young and old 
sample groups, and one named LV (Low Variance), generated with those probes where 
both young and old variances were below the 25th percentile. 
The in silico functional analysis and interpretation of the groups of genes established 
according to the behavior of the variance in blood was performed using the Database for 
Annotation, Visualization and Integrated Discovery (DAVID) and the "Gene ontology" 
and “UP_TISSUE" categories (Dennis et al. 2003; Huang da et al. 2009). 
Measuring intra- and interindividual distance 
Euclidean distances between twins were computed for every probe in the original Twins 
dataset, using beta-values. In a simple scenario, the Euclidean distance accounts for the 
absolute difference between the beta values of the two siblings. Differences in distances 
were computed as the base-2 logarithm of the fold change between the average 
Euclidean distance for the young and old sample groups.  
Histone enrichment analysis 
In order to analyze the enrichment of a histone mark on a given subset of probes, we 
used the information contained in the UCSC Genome Browser Broad Histone track 
from the ENCODE Project (Rosenbloom et al. 2010; Rosenbloom et al. 2012) 
(Supplemental Table 26). Histone peak data for every histone modification and 
chromatin modifier in hESCs and 10 different cell types obtained from healthy 
individuals were downloaded from the UCSC Genome Browser. Small peaks were 
discarded when they were completely contained within wider peaks. Following the 
ENCODE Broad Histone Methods description, discrete intervals of ChIP-seq fragment 
enrichment were identified using Scripture, a scan statistics approach, under the 
assumption of uniform background signal (http://genome.ucsc.edu//cgi-
bin/hgTrackUi?db=hg19&g=wgEncodeBroadHistone). 
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For each combination of cell line and mark, a 2x2 contingency table was built to 
determine its association with the input subset of probes. Probes in the array were 
classified according to whether they belonged to the subset or not, and whether they 
intersected with a significant broad peak for the given combination of cell line and 
mark. A Fisher´s exact test was used to determine if the given subset of probes was 
significantly enriched for each combination of cell line and mark. P-values were 
corrected for multiple testing using FDR (Benjamini-Hochberg method) and a 
significance level of 0.05 was used to determine which probes had significant 
enrichment. The base-2 logarithm of the Odds Ratio was used as a measure of effect 
size. 
Genomic region analysis 
The probes in the microarray were assigned a genomic region according to their 
position relative to the transcript information extracted from the R/Bioconductor 
package TxDb.Hsapiens.UCSC.hg19.knownGene (Carlson). A probe was said to be in a 
Promoter region if it was located inside the first exon, the 5'-UTR or a region up to 
2kbp upstream of the transcription start site (TSS) of any given transcript. Similarly, a 
probe was labeled as Intragenic if it was inside any intron or any exon other than the 
first. Intergenic probes were determined as those not falling into either of the two 
previous categories. According to this definition, a probe could be in both a Promoter 
and an Intragenic region at the same time for different transcripts. A contingency table 
was built for each selected subset of probes and a given genomic region, with one 
variable indicating whether a given probe belonged or not to the subset, and the other 
indicating whether a given probe was labeled with the selected region. Significance of 
the association was determined by a Pearson's chi-squared test with Yates' continuity 
correction. A significance level of 0.05 was used to determine whether a subset was 
dependent with respect to a given genomic region. Odds Ratio was used as a measure of 
effect size. 
CpG Island status analysis 
The CpG island locations used in the analyses were obtained from the R/Bioconductor 
package FDb.InfiniumMethylation.hg19 (Triche 2013) The generation procedure of 
these CpG Islands is described by Wu and colleagues (Wu et al. 2010). CpG shores 
were defined as the 2kbp regions flanking a CpG Island. CpG shelves were defined as 
the 2kbp region either upstream or downstream of each CpG shore. Probes not 
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belonging to any of the regions thus far mentioned were assigned to the special category 
Non-CpG Island. Each probe was assigned to only one of the categories. A 4x2 
contingency table was constructed for every subset of probes in order to study the 
association between the given subset and the different CpG Island categories. A chi-
squared test was used to determine if any of the categories had a significant association 
with the given subset. For each of the CpG Island status levels, a 2x2 contingency table 
was defined and another chi-squared test was used to independently evaluate the 
association of the given subset with each status level, a significance level of 0.05 being 
employed for all tests. Effect size was reported as the Odds Ratio for each of the 
individual tests. 
Microarray background correction 
Although it is sometimes referred to as a genome wide solution, the 
HumanMethylation450 BeadChip only covers a fraction of the entire genome. In its 27k 
predecessor, the probes were mainly located at gene promoter regions, while in addition 
to the promoter probes, the HumanMethylation450 BeadChip includes probes located 
inside genes and in intergenic regions (Dedeurwaerder et al. 2011). 
The irregular distribution of probes can lead to unwanted biases when studying whether 
a selected subset of probes is enriched with respect to any functional or clinical mark. A 
reference to the background distribution of features was included in every type of 
statistical test performed in order to prevent our conclusions from being driven by the 
irregular distribution of probes. In qualitative tests (CpG Island status, genomic region 
or histone mark enrichment), the contingency matrix was built to represent the 
background distribution of the microarray. Thus, any significant result would indicate a 
departure from the fixed background distribution, and ignore any manufacturer bias. 
Circos data track smoothing 
In order to plot the CpG information on the Circos genome-wide graphs (Krzywinski et 
al. 2009), smoothing was applied to our data. Broad histone peak information from 
UCSC Genome Browser was averaged by partitioning the genome into intervals of 
200kbp and assigning to each a score corresponding to the average of the broad peak 
scores found within it. CpG locations were not smoothed. Distances in the Twins 
dataset were averaged using a 2Mbp window size. 
Bisulfite pyrosequencing 
DNA methylation patterns of representative dmCpGs during aging were analyzed by 
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bisulfite pyrosequencing in an independent sample set of 46 MSCs obtained from 
individuals of different ages (Supplemental Table 1). Bisulfite modification of DNA 
was performed with the EZ DNA Methylation-Gold kit (Zymo Research) following the 
manufacturer's instructions. The set of primers for PCR amplification and sequencing 
were designed using the specific software PyroMark assay design (version 2.0.01.15). 
Primer sequences were designed to hybridize with CpG free sites to ensure methylation-
independent amplification (Supplemental Table 27). After PCR amplification of the 
region of interest with the specific primers, pyrosequencing was performed using 
PyroMark Q24 reagents, and vacuum prep workstation, equipment and software 
(Qiagen). A linear regression model was fitted to the pyrosequencing methylation data 
using age as a predictor. 
Data analysis workflow 
All the necessary steps for upstream and downstream analyses were defined and 
implemented using the Snakemake tool (Köster and Rahmann 2012). This tool helps 
data scientists to generate a reproducible and inherently parallel processing pipeline. 
The source code of the workflow is included as Supplemental Material. 
Data access 
The HumanMethylation450 BeadChip data sets from this study have been submitted to 
the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under 
accession number GSE52114 (SubSeries GSE52112 and GSE52113). 
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Figure legends 
Figure1. DNA methylation changes during MSC aging. (A) Unsupervised hierarchical 
clustering and heatmap including the 15000 most variable CpG sites with differential 
DNA methylation between young and old MSCs. Average methylation values are 
displayed from 0 (blue) to 1 (yellow). (B) Density plot for differentially methylated 
CpG sites between representative young (two years old; 2-yo) and old (87 years old; 87-
yo) MSCs.  (C) Distribution of differentially methylated CpGs relative to CpG Island. 
(D) Relative distribution of differentially methylated CpGs across different genomic 
regions. (E) Examples of aging-specific CpG methylation in particular genes further 
validated by pyrosequencing in an independent set of samples. For each of the genes of 
interest, a scatter plot of the percentage of methylation obtained for each sample and 
CpG of interest is shown. The two genes at the top show an age-dependent 
hypermethylation tendency, while the three genes at the bottom show hypomethylation 
with respect to age. Each point represents a single observation for a given sample and 
CpG of interest. The blue line represents a linear model fit. A 0.95 confidence interval 
of the fitted model is shown in gray. (F) Venn diagrams showing the number of CpG 
sites (hyper- and hypomethylated) shared by the different tissues 
Figure2. Chromatin signatures associated with DNA methylation changes during aging. 
(A) Heatmaps showing significant enrichment of hyper- and hypomethylated CpG sites,  
identified in MSCs, blood, neurons and glia, with different histone marks and chromatin 
modifiers contained in the UCSC Genome Browser Broad Histone track from the 
ENCODE Project. Color code indicates the significant enrichment based on log2 odds 
ratio (OR). (B) Circular representation of three representative chromosomes (1, 6, and 
17), indicating whether the CpGs were hypermethylated (red) or hypomethylated (blue) 
during MSC aging. Inner tracks display chromatin marks (H3K4me1, H3K9me3, 
H3K27me3, and EZH2), generated for HUVEC cells, and associated with differentially 
methylated regions during aging. Broad histone peak information was averaged in 200 
kbp genomic windows and represented as histogram tracks. Three examples of hypo- 
and hypermethylated DNA regions associated with specific chromatin signatures are 
displayed below. 
Figure3. Interindividual DNA methylation variability during MSC aging. (A) Density 
plot for CpG sites showing significant changes in variance in young and old MSCs.  (B) 
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Bar plot showing the number of age-dependent heteroscedastic (convergent and 
divergent) and homoscedastic (high (HV) and low (LV) variability) CpG sites in MSCs. 
(C) Box plots showing the classification of CpG sites into different groups based on the 
aging-dependent behavior of the interindividual variability. Representative examples of 
CpG sites for each group are shown below (mvalue: relative methylation values). (D) 
Distribution of homoscedastic and heteroscedastic CpGs relative to CpG island status 
and relative distribution across different genomic regions. 
Figure4. Interindividual DNA methylation variability during aging of blood cells. (A) 
Density plot for CpG sites showing significant changes of variance in young and old 
individuals.  (B) Bar plot showing the number of age-dependent heteroscedastic 
(convergent and divergent) and homoscedastic (high (HV) and low (LV) variability) 
CpG sites. (C) Box plots showing the classification of the CpG sites in different groups 
based on the aging-dependent behavior of the interindividual variability. 
Figure5. Role of genetic factors in interindividual DNA methylation variability during 
aging. (A) Density plot for CpG sites showing significant changes of methylation 
variance in blood cells of MZ twins during aging. (B) Density plot for comparison 
between the mean Euclidean distance (⎯δ)  and the interindividual variability (σ2) in 
methylation values between old and young MZ twins. The horizontal dotted lines 
represent a 2 fold change in the ⎯δ between MZ twins. (C) Circular representation of 
genome-wide CpG sites showing differences, in the ⎯δ between methylation values of 
young and old MZ twins. δ was averaged using a 2Mbp window size. Inner tracks show 
genomic regions where the ⎯δ was higher (blue region) or lower (green region) in old 
compared with young MZ twins.  (D) Density plots for comparison between the ⎯δ and 
the σ2 in methylation values between old and young MZ twins, in hyper-, 
hypomethylated, heteroscedastic and homoscedastic CpGs. 
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